Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cardiovascular risk factor reduction clinic.

T W Wilson1, D W Quest, M Wilson

  • 1University of Saskatchewan, Saskatoon, Canada. wilsont@duke.usask.ca

The Canadian Journal of Cardiology
|August 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Master Two-Step Test.

Canadian Medical Association journal·2010
Same author

Antemortem Diagnosis of Paradoxic Embolism.

Canadian Medical Association journal·2010
Same author

The protective action of thyroid and potassium iodide in cholesterol induced atherosclerosis in chickens.

Federation proceedings·2010
Same author

Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis.

Journal of clinical pathology·2004
Same author

Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans.

American journal of hypertension·2000
Same author

Fenofibrate lowers blood pressure in two genetic models of hypertension.

Canadian journal of physiology and pharmacology·2000
Same journal

Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease.

The Canadian journal of cardiology·2026
Same journal

Storm Clouds Coming: Red-Flag Warning for Hypertension Prevalence and Control in the Post-COVID-19 Era.

The Canadian journal of cardiology·2026
Same journal

Universal coverage, unequal care: Why Canada needs a national cardiovascular access ledger.

The Canadian journal of cardiology·2026
Same journal

Prolonged Loop Recorder Retention: Safety, Diagnostic Yield, and the Case for Community-Based Explantation.

The Canadian journal of cardiology·2026
Same journal

Multimodality Fusion Imaging of Subclinical Systemic Right Ventricular Remodeling in Congenitally Corrected Transposition of the Great Arteries.

The Canadian journal of cardiology·2026
Same journal

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
See all related articles

A cardiovascular risk factor reduction unit (CRFRU) is feasible and effectively reduces coronary artery disease (CAD) risk in high-risk patients. Improvements were seen in blood pressure, lipid profiles, and weight loss after one year.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • Early identification and management of cardiovascular risk factors are crucial for prevention.
  • Specialized units can provide focused interventions for high-risk populations.

Purpose of the Study:

  • To describe the characteristics of patients referred to a cardiovascular risk factor reduction unit (CRFRU).
  • To evaluate the feasibility and effectiveness of a CRFRU in reducing coronary artery disease (CAD) risk.
  • To compare the risk profile of referred patients with the general population.

Main Methods:

  • Prospective cohort study of 704 outpatients with cardiovascular risk factors.
  • Assessment of CAD probability using the Framingham equation.

Related Experiment Videos

  • Interventions included lifestyle advice and pharmacotherapy.
  • Follow-up reassessment after one year for 388 patients.

    • Main Results:

    • Referred patients exhibited significantly higher CAD risk compared to the general population.
    • A considerable proportion of patients achieved a reduced risk score after one year.
    • Improvements were associated with favorable changes in systolic blood pressure, lipid profiles, and weight loss.

    Conclusions:

    • A CRFRU is a feasible model for cardiovascular risk management.
    • The unit demonstrated effectiveness in reducing CAD risk in a significant patient cohort.
    • Targeted interventions can lead to measurable improvements in modifiable risk factors.